Hims & Hers Health HIMS
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Hims & Hers Health (HIMS) Business Model and Operations Summary
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.
Key Insights
Hims & Hers Health (HIMS) Core Market Data and Business Metrics
Latest Closing Price
$31.05Market Cap
$6.91 BillionPrice-Earnings Ratio
58.58Total Outstanding Shares
213.79 Million SharesTotal Employees
1,637Dividend
No dividendIPO Date
January 21, 2021SIC Description
Services-offices & Clinics Of Doctors Of MedicinePrimary Exchange
New York Stock ExchangeHeadquarters
2269 Chestnut St, San Francisco, CA, 94123
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Operating Activities | $251.08 Million |
| Net Cash Flow | $123.92 Million |
| Net Cash Flow From Operating Activities, Continuing | $251.08 Million |
| Net Cash Flow From Financing Activities, Continuing | $-107.84 Million |
| Net Cash Flow, Continuing | $124.19 Million |
| Net Cash Flow From Investing Activities, Continuing | $-19.05 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Income/Loss From Continuing Operations Before Tax | $71.71 Million |
| Diluted Average Shares | $236.81 Million |
| Income Tax Expense/Benefit | $-54.33 Million |
| Nonoperating Income/Loss | $9.81 Million |
| Net Income/Loss Available To Common Stockholders, Basic | $126.04 Million |
| Basic Average Shares | $215.94 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $125.84 Million |
| Other Comprehensive Income/Loss Attributable To Parent | $-200,000 |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Other Comprehensive Income/Loss | $125.84 Million |
| Comprehensive Income/Loss Attributable To Parent | $125.84 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Liabilities | $230.82 Million |
| Noncurrent Assets | $311.71 Million |
| Intangible Assets | $43.41 Million |
| Equity Attributable To Noncontrolling Interest | $0 |
| Inventory | $64.43 Million |
| Equity | $476.72 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||